Amlan Datta/LinkedIn
Apr 9, 2026, 13:52
Amlan Datta: When Do We Actually Use Dual Antiplatelet Therapy in Stroke Prevention?
Amlan Datta, Assistant Professor at Jagannath Gupta Institute of Medical Sciences and Hospital in North Kolkata and Consultant Neurologist at Narayana Health and Zenith Super Specialist Hospital, shared a post on LinkedIn:
”When do we actually use Dual Anti-Platelet Therapy (DAPT) in stroke prevention?
The guidelines have evolved significantly, moving beyond simple aspirin use for many patients. Here’s a concise breakdown of the current AHA/ASA recommendations — essential for any physician managing these cases.
- Minor Stroke / High-risk TIA: If a patient has a minor stroke (NIHSS ≤ 3) or a high-risk TIA (ABCD² ≥ 4), the evidence from the CHANCE and POINT trials supports starting DAPT within 24 hours. This aggressive approach continues for 21 days, which is the highest-risk period for recurrence.
- After Carotid Intervention (CAS): Following carotid artery stenting, DAPT is mandatory to prevent early stent thrombosis while the vessel heals. According to CREST protocols, this duration is typically 30 days.
- Intracranial Large-Vessel Stenosis: For symptomatic 70-99% stenosis of a major intracranial artery, the SAMMPRIS trial indicates that aggressive medical therapy is effective. Here, DAPT is recommended for a full 90 days.
The key takeaway? Timing and duration are paramount, always balancing the significant reduction in recurrent ischemic events against the increased bleeding risk.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health